RituximabVarious infusion-related reactions: 2 case reports

被引：0
|
作者：
机构：
来源：
Reactions Weekly | 2021年 / 1853卷 / 1期
关键词：
D O I：
10.1007/s40278-021-95289-y
中图分类号：
学科分类号：
摘要：
引用
下载
收藏
页码：423 / 423
相关论文
共 50 条
  • [21] Successful rechallenge of cetuximab following severe infusion-related reactions: a case report
    Chang, Pei-Hung
    Huang, Jen-Seng
    CHINESE JOURNAL OF CANCER RESEARCH, 2014, 26 (01) : E10 - E12
  • [22] TreprostinilErythema, infusion-related reactions and implant-site pain: case report
    Reactions Weekly, 2021, 1859 (1) : 348 - 348
  • [23] RituximabVarious toxicities: 2 case reports
    Reactions Weekly, 2017, 1663 (1) : 266 - 266
  • [24] RituximabVarious toxicities: 2 case reports
    Reactions Weekly, 2022, 1929 (1) : 568 - 568
  • [25] Multiple drugsAbdominal pain, infusion-related reaction and lack of efficacy: 4 case reports
    Reactions Weekly, 2021, 1869 (1) : 236 - 236
  • [26] RituximabVarious toxicities: 2 case reports
    Reactions Weekly, 2019, 1776 (1) : 400 - 400
  • [27] RituximabVarious toxicities: 2 case reports
    Reactions Weekly, 2018, 1706 (1) : 445 - 445
  • [28] Infusion-related hypersensitivity reactions during natalizumab treatment
    Phillips, J. T.
    O'Connor, P. W.
    Havrdova, E.
    Hutchinson, M.
    Kappos, L.
    Miller, D. H.
    Polman, C. H.
    Lublin, F. D.
    Giovannoni, G.
    Wajgt, A.
    Lynn, F.
    Panzara, M. A.
    NEUROLOGY, 2006, 67 (09) : 1717 - 1718
  • [29] Infusion-related reactions with ocrelizumab in phase III studies
    de Seze, J.
    Hauser, S. L.
    Kappos, L.
    Montalban, X.
    Pozzilli, C.
    Chognot, C.
    Julian, L.
    Koendgen, H.
    Zheng, H.
    Wolinsky, J. S.
    MULTIPLE SCLEROSIS JOURNAL, 2017, 23 : 878 - 879
  • [30] Optimizing Premedications in the Prevention of Bendamustine Infusion-Related Reactions
    Tombleson, Rebecca L.
    Viet Ho
    Sokol, Lubomir
    Pinilla, Javier
    Wetzstein, Gene A.
    CANCER CONTROL, 2012, 19 (03) : 245 - 247
12345